Innovotech Inc. is a biotechnology company focused on developing and marketing solutions for the treatment and diagnosis of infectious diseases. Through its proprietary platforms, Innovotech conducts research to combat antibiotic-resistant bacteria, a significant concern in the healthcare sector. The company's range of products includes diagnostic tests that provide rapid and accurate identification of pathogens, as well as antimicrobial susceptibility testing. Innovotech engages with sectors such as healthcare, pharmaceuticals, and agriculture, providing advanced technological solutions to improve health outcomes. Headquartered in Canada, Innovotech contributes to the global effort against emerging and persisting threats of infectious diseases by enhancing the efficacy and safety of antibiotics. Its research-driven approach positions it as a notable player in the biotechnological landscape, addressing critical needs in the diagnostics and therapeutics market for both human and animal health.